New Microchip Sensor Measures Stress Hormones from Drop of Blood

Translate to Spanish or other 102 languages!

A depiction of stress molecules in blood electronically being detected inside nano-wells. By Ella Marushchenko

Mega Doctor News

- Advertisement -

Newswise — New Brunswick, N.J. – A Rutgers-led team of researchers has developed a microchip that can measure stress hormones in real time from a drop of blood. 

The study appears in the journal Science Advances

Cortisol and other stress hormones regulate many aspects of our physical and mental health, including sleep quality. High levels of cortisol can result in poor sleep, which increases stress that can contribute to panic attacks, heart attacks and other ailments. 

- Advertisement -

Currently, measuring cortisol takes costly and cumbersome laboratory setups, so the Rutgers-led team looked for a way to monitor its natural fluctuations in daily life and provide patients with feedback that allows them to receive the right treatment at the right time. 

The researchers used the same technologies used to fabricate computer chips to build sensors thinner than a human hair that can detect biomolecules at low levels. They validated the miniaturized device’s performance on 65 blood samples from patients with rheumatoid arthritis. 

“The use of nanosensors allowed us to detect cortisol molecules directly without the need for any other molecules or particles to act as labels,” said lead author Reza Mahmoodi, a postdoctoral scholar in the Department of Electrical and Computer Engineering at Rutgers University-New Brunswick. 

With technologies like the team’s new microchip, patients can monitor their hormone levels and better manage chronic inflammation, stress and other conditions at a lower cost, said senior author Mehdi Javanmard, an associate professor in Rutgers’ Department of Electrical and Computer Engineering. 

- Advertisement -

“Our new sensor produces an accurate and reliable response that allows a continuous readout of cortisol levels for real-time analysis,” he added. “It has great potential to be adapted to non-invasive cortisol measurement in other fluids such as saliva and urine. The fact that molecular labels are not required eliminates the need for large bulky instruments like optical microscopes and plate readers, making the readout instrumentation something you can measure ultimately in a small pocket-sized box or even fit onto a wristband one day.”  The study included Rutgers co-author Pengfei Xie, a Ph.D. student, and researchers from the University of Minnesota and University of Pennsylvania. The research was funded by the DARPA ElectRX program.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Transplant Success Signals a New Era for Advanced Medicine in the Rio Grande Valley

The significance of DHR Health Transplant Institute’s latest recognition extends far beyond a hospital ranking. It raises a larger question for South Texas: Has the Rio Grande Valley reached the point where patients can look to the region not only for local healthcare, but for nationally competitive transplant medicine?

STHS Earns Another 5-Star Healthgrades Distinction for Hip Fracture Care

For the sixth consecutive year, STHS McAllen and STHS Edinburg have earned a Five-Star Rating for Hip Fracture Treatment from Healthgrades, one of the nation's leading resources for evaluating hospital performance.

Raising Awareness, One Step at a Time: STHS Edinburg Hosts Sept. 23 Walkathon

To raise awareness about the condition and encourage residents to take proactive steps toward better vascular health, the STHS Limb Salvage & Amputation Prevention Program will host the Step Out PAD Walkathon on Wednesday, September 23, 2026, at STHS Edinburg, from 6:30 to 7:30 p.m.

FDA Launches Expedited IND Pilot to Speed Up Clinical Trials

The U.S. Food and Drug Administration today announced the final design of the Expedited Investigational New Drug (IND) Pilot. Accelerating clinical trial timelines and eliminating regulatory hurdles to maintain American leadership in global medical innovation is a core priority for the Trump Administration.
- Advertisement -